Tag: acquisition

February 16, 2017 Off

Stada confirms another bidder

By Dino Mustafić

On Thursday, STADA Arzneimittel AG confirmed that it has received another legally non-binding conditional expression of interest regarding a bid for the acquisition of up to 100 percent of the shares in the company at an indicative takeover price of €58.00 per share.

January 20, 2017 Off

Sanofi’s M&A misses frustrate some investors in drugmaker

By Dino Mustafić

For the last year, Sanofi’s chief executive has made clear his quest for deals to help revive the fortunes of France’s biggest drugmaker.

The market is still waiting. Olivier Brandicourt’s failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors.

January 17, 2017 Off

Onzima buys remaining 51% of N4 Pharma

By Dino Mustafić

Onzima Ventures said on Tuestday it would buy another 51% of N4 Pharma Limited shares with 34609210 new ordinary shares of of 0.1p each in its capital. The acquisition should be completed by mid-April 2017.